From a mechanistic standpoint, reduced IL-10 transcription linked to promoter polymorphisms may impair the anti-inflammatory capacity of the preterm lung, favoring cytokine-mediated alveolar injury and progression to severe RDS, as described in cord blood and pulmonary cell studies [9]. The gene discussed is IL10; the disease is newborn respiratory distress syndrome.